About
Contact & Profiles
A5024963642
Research Areas
- Metabolism, Diabetes, and Cancer
- Neuroendocrine Tumor Research Advances
- Diabetes Treatment and Management
Cathay General Hospital
2022
Objectives Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF mortality among with cancer diabetes. Methods This was a retrospective propensity score-matched cohort study involving adult type 2 diabetes mellitus diagnosed between January 2010 December 2021. The primary outcomes were hospitalisation for incident all-cause mortality. secondary serious adverse events...
10.1136/heartjnl-2022-321545
article
EN
Heart
2022-11-09
Coming Soon ...